Mutations in Escherichia coli aceE and ribB Genes Allow Survival of Strains Defective in the First Step of the Isoprenoid Biosynthesis Pathway

Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Güeto, Susanna; Lois, L. Maria; Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.; Boronat, Albert; Rodriguez-Concepcion, Manuel; McCutcheon, John
August 2012
PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1
Academic Journal
A functional 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway is required for isoprenoid biosynthesis and hence survival in Escherichia coli and most other bacteria. In the first two steps of the pathway, MEP is produced from the central metabolic intermediates pyruvate and glyceraldehyde 3-phosphate via 1- deoxy-D-xylulose 5-phosphate (DXP) by the activity of the enzymes DXP synthase (DXS) and DXP reductoisomerase (DXR). Because the MEP pathway is absent from humans, it was proposed as a promising new target to develop new antibiotics. However, the lethal phenotype caused by the deletion of DXS or DXR was found to be suppressed with a relatively high efficiency by unidentified mutations. Here we report that several mutations in the unrelated genes aceE and ribB rescue growth of DXS-defective mutants because the encoded enzymes allowed the production of sufficient DXP in vivo. Together, this work unveils the diversity of mechanisms that can evolve in bacteria to circumvent a blockage of the first step of the MEP pathway.


Related Articles

  • Novel approaches and achievements in biosynthesis of functional isoprenoids in Escherichia coli. Harada, Hisashi; Misawa, Norihiko // Applied Microbiology & Biotechnology;Oct2009, Vol. 84 Issue 6, p1021 

    Isoprenoids, also referred to as terpenes, are the most diverse class of natural products appearing in a variety of natural sources, specifically in higher plants, and have a wide range of biological functions. This review describes novel or recent approaches and achievements in pathway...

  • Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Martin, Vincent J J; Pitera, Douglas J; Withers, Sydnor T; Newman, Jack D; Keasling, Jay D // Nature Biotechnology;Jul2003, Vol. 21 Issue 7, p796 

    Isoprenoids are the most numerous and structurally diverse family of natural products. Terpenoids, a class of isoprenoids often isolated from plants, are used as commercial flavor and fragrance compounds and antimalarial or anticancer drugs. Because plant tissue extractions typically yield low...

  • Carbon partitioning to the terpenoid biosynthetic pathway enables heterologous β-phellandrene production in Escherichia coli cultures. Formighieri, Cinzia; Melis, Anastasios // Archives of Microbiology;Dec2014, Vol. 196 Issue 12, p853 

    Escherichia coli was used as a microbial system for the heterologous synthesis of β-phellandrene, a monoterpene of plant origin with several potential commercial applications. Expression of Lavandula angustifolia β-phellandrene synthase ( PHLS), alone or in combination with Picea abies...

  • Combinatorial biosynthesis of flavones and flavonols in Escherichia coli. Miyahisa, Ikuo; Funa, Nobutaka; Ohnishi, Yasuo; Martens, Stefan; Moriguchi, Takaya; Horinouchi, Sueharu // Applied Microbiology & Biotechnology;Jun2006, Vol. 71 Issue 1, p53 

    (2 S)-Flavanones (naringenin and pinocembrin) are key intermediates in the flavonoid biosynthetic pathway in plants. Recombinant Escherichia coli cells containing four genes for a phenylalanine ammonia-lyase, cinnamate/coumarate:CoA ligase, chalcone synthase, and chalcone isomerase, in addition...

  • Pathway optimization by re-design of untranslated regions for L-tyrosine production in Escherichia coli. Cheol Kim, Seong; Eun Min, Byung; Gyu Hwang, Hyun; Woo Seo, Sang; Yeol Jung, Gyoo // Scientific Reports;9/11/2015, p13853 

    L-tyrosine is a commercially important compound in the food, pharmaceutical, chemical, and cosmetic industries. Although several attempts have been made to improve L-tyrosine production, translation-level expression control and carbon flux rebalancing around phosphoenolpyruvate (PEP) node still...

  • Metabolic engineering of indole pyruvic acid biosynthesis in Escherichia coli with tdiD. Yelin Zhu; Yan Hua; Biao Zhang; Lianhong Sun; Wenjie Li; Xin Kong; Jiong Hong // Microbial Cell Factories;1/3/2017, Vol. 16, p1 

    Background: Indole pyruvic acid (IPA) is a versatile platform intermediate and building block for a number of highvalue products in the pharmaceutical and food industries. It also has a wide range of applications, such as drugs for the nervous system, cosmetics, and luminophores. Chemical...

  • Computational identification of gene over-expression targets for metabolic engineering of taxadiene production. Boghigian, Brett; Armando, John; Salas, Daniel; Pfeifer, Blaine // Applied Microbiology & Biotechnology;Mar2012, Vol. 93 Issue 5, p2063 

    Taxadiene is the first dedicated intermediate in the biosynthetic pathway of the anticancer compound Taxol. Recent studies have taken advantage of heterologous hosts to produce taxadiene and other isoprenoid compounds, and such ventures now offer research opportunities that take advantage of the...

  • A novel fungal prenyl diphosphate synthase in the dimorphic zygomycete Mucor circinelloides. Velayos, Antonio; Fuentes-Vicente, Mónica; Aguilar-Elena, Raúl; Eslava, Arturo P.; Iturriaga, Enrique A. // Current Genetics;Jun2004, Vol. 45 Issue 6, p371 

    Two Mucor circinelloides structural genes involved in isoprenoid biosynthesis were isolated and characterised. The isoA gene encodes a typical eukaryotic farnesyl diphosphate synthase (EC, whereas the isoB gene deduced amino acid sequence shows similarity to fungal medium-chain prenyl...

  • Simultaneous production and partitioning of heterologous polyketide and isoprenoid natural products in an Escherichia coli two-phase bioprocess. Boghigian, Brett; Myint, Melissa; Wu, Jiequn; Pfeifer, Blaine // Journal of Industrial Microbiology & Biotechnology;Nov2011, Vol. 38 Issue 11, p1809 

    Natural products have long served as rich sources of drugs possessing a wide range of pharmacological activities. The discovery and development of natural product drug candidates is often hampered by the inability to efficiently scale and produce a molecule of interest, due to inherent qualities...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics